Abstract
Background Glucocorticoids play a crucial role as mediators of negative health effects associated with chronic stress, including increased risk for psychiatric disorders as well as cardiovascular and metabolic diseases. This study investigates the impact of genetic variants and glucocorticoid receptor (GR)-activation on gene expression and DNA methylation in peripheral blood and the relationship of these variants with disease risk.
Methods We conducted a comprehensive molecular quantitative trait locus (QTL) analysis, mapping GR-methylation (me)QTLs, GR-expression (e)QTLs, and GR-expression quantitative trait methylation (eQTM) in a cohort of 199 individuals, with DNA methylation and RNA expression data collected before and after GR-activation with dexamethasone. A multi-level network analysis was employed to map the complex relationships between the transcriptome, epigenome, and genetic variation.
Results We identified 3,772 GR-meQTL CpGs corresponding to 104,828 local GR-meQTLs. eQTM and eQTL analyses revealed distinct genetic influences on RNA expression and DNA methylation. Multi-level network analysis uncovered GR-network trio QTLs, characterized by SNP-CpG-transcript combinations where meQTLs act as both eQTLs and eQTMs. These trios’ genes demonstrated enrichment in immune response and cell activation pathways and showed a significant overlap with transcripts altered by GR-activation in the mouse brain. GR-trio variants were enriched in GWAS for bipolar disorder, schizophrenia, autoimmune and cardiovascular diseases, along with associated traits, cytokines levels, and BMI.
Conclusions Genetic variants modulating the molecular effects of glucocorticoids are associated with psychiatric as well as medical diseases. Our findings support stress as a shared risk factor for transdiagnostic negative health outcomes and may lead to innovative interventions targeting shared underlying molecular mechanisms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No 860895, European Training Network grant, Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine (TranSYS), and European Research Council (ERC) starting grant number 281338, ''Gene x environment interactions in affective disorders - elucidating molecular mechanisms'' (GxE molmech) to Elisabeth Binder. Dr. Knauer-Arloth's contributions were supported by the Brain & Behavior Research Foundation (NARSAD Young Investigator Grant, No 28063).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the ethics board of the Ludwig Maximilians University (approval #244/01) and was conducted in accordance with the current version of the Declaration of Helsinki.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos